Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

AmCad BioMed Corporation (4188) Income Statement

AmCad BioMed Corporation Income Statement

Last quarter (Q2 2026), AmCad BioMed Corporation's total revenue was NT$6.72M, a decrease of 17.66% from the same quarter last year. In Q2, AmCad BioMed Corporation's net income was NT$-15.11M. See AmCad BioMed Corporation’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 30.44MNT$ 53.10MNT$ 65.26MNT$ 61.63MNT$ 85.79M
NT$ 10.02MNT$ 32.93MNT$ 41.02MNT$ 38.05MNT$ 60.66M
NT$ 97.98MNT$ 97.60MNT$ 95.01MNT$ 102.39MNT$ 97.53M
Depreciation and AmortizationNT$ 15.80MNT$ 18.28MNT$ 17.46MNT$ 17.63MNT$ 18.28M
NT$ -55.52MNT$ -34.41MNT$ -25.56MNT$ -36.60MNT$ -8.46M
NT$ -87.95MNT$ -64.66MNT$ -53.98MNT$ -54.28MNT$ -26.84M
NT$ 16.55MNT$ 11.79MNT$ 10.84MNT$ 9.95MNT$ 9.88M
NT$ -71.40MNT$ -52.88MNT$ -43.15MNT$ -54.34MNT$ -26.89M
NT$ -55.72MNT$ -50.58MNT$ -45.31MNT$ -53.49MNT$ -25.54M
Per Share Metrics
Basic EPSNT$ -0.88NT$ -0.88NT$ -0.83NT$ -1.01NT$ -0.48
Diluted EPSNT$ -0.88NT$ -0.88NT$ -0.83NT$ -1.01NT$ -0.48
Weighted Average Shares Outstanding63.32M57.71M54.41M53.22M53.22M
Weighted Average Shares Outstanding (Diluted)63.32M57.71M54.41M53.22M53.22M

Currency in TWD

AmCad BioMed Corporation Earnings and Revenue History

-80M080M160M-240 %-160 %-80 %0 %EarningsProfit Margin202020212022202320242025RevenueEarningsProfit Margin